Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports. Wall Street Zen cut shares of Collegium Pharmaceutical from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 25th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Collegium Pharmaceutical in a research report on Monday, July 6th. Get Collegium Pharmaceutical alerts:Get Our Latest Analysis on COLLCollegium Pharmaceutical Stock PerformanceCollegium Pharmaceutical stock opened at $36.29 on Tuesday. Recommended StoriesReceive News & Ratings for Collegium Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collegium Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.